Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9973 USD | -3.17% |
|
+10.43% | -8.50% |
05-21 | Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium | CI |
05-09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.50% | 188M | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.73% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- Transcript : Lineage Cell Therapeutics, Inc., Q4 2022 Earnings Call, Mar 09, 2023